|
1
|
Bruix J, Gores GJ and Mazzaferro V:
Hepatocellular carcinoma: clinical frontiers and perspectives. Gut.
63:844–855. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Friedl P and Alexander S: Cancer invasion
and the microenvironment: plasticity and reciprocity. Cell.
147:992–1009. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chiang AC and Massagué J: Molecular basis
of metastasis. N Engl J Med. 359:2814–2823. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chambers AF, Groom AC and MacDonald IC:
Dissemination and growth of cancer cells in metastatic sites. Nat
Rev Cancer. 2:563–572. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stock AM, Troost G, Niggemann B, Zänker KS
and Entschladen F: Targets for anti-metastatic drug development.
Curr Pharm Des. 19:5127–5134. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xiu LJ, Sun DZ, Jiao JP, Yan B, Qin ZF,
Liu X, Wei PK and Yue XQ: Anticancer effects of traditional Chinese
herbs with phlegm-eliminating properties - an overview. J
Ethnopharmacol. 172:155–161. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shu L, Cheung KL, Khor TO, Chen C and Kong
AN: Phytochemicals: cancer chemoprevention and suppression of tumor
onset and metastasis. Cancer Metastasis Rev. 29:483–502. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Korkina LG, De Luca C, Kostyuk VA and
Pastore S: Plant poly-phenols and tumors: from mechanisms to
therapies, prevention, and protection against toxicity of
anti-cancer treatments. Curr Med Chem. 16:3943–3965. 2009.
View Article : Google Scholar
|
|
10
|
Yang G and An HJ:
β-sitosteryl-3-O-β-glucopyranoside isolated from the bark of Sorbus
commixta ameliorates pro-inflammatory mediators in RAW 264.7
macrophages. Immunopharmacol Immunotoxicol. 36:70–77. 2014.
View Article : Google Scholar
|
|
11
|
Yu T, Lee YJ, Jang HJ, Kim AR, Hong S, Kim
TW, Kim MY, Lee J, Lee YG and Cho JY: Anti-inflammatory activity of
Sorbus commixta water extract and its molecular inhibitory
mechanism. J Ethnopharmacol. 134:493–500. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bae JT, Sim GS, Kim JH, Pyo HB, Yun JW and
Lee BC: Antioxidative activity of the hydrolytic enzyme treated
Sorbus commixta Hedl. and its inhibitory effect on matrix
metalloproteinase-1 in UV irradiated human dermal fibroblasts. Arch
Pharm Res. 30:1116–1123. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Raudonė L, Raudonis R, Gaivelytė K,
Pukalskas A, Viškelis P, Venskutonis PR and Janulis V:
Phytochemical and antioxidant profiles of leaves from different
Sorbus L. species. Nat Prod Res. 29:281–285. 2015. View Article : Google Scholar
|
|
14
|
Kang DG, Sohn EJ, Lee AS, Kim JS, Lee DH
and Lee HS: Methanol extract of Sorbus commixta cortex prevents
vascular inflammation in rats with a high fructose-induced
metabolic syndrome. Am J Chin Med. 35:265–277. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sohn EJ, Kang DG, Mun YJ, Woo WH and Lee
HS: Anti-atherogenic effects of the methanol extract of Sorbus
cortex in atherogenic-diet rats. Biol Pharm Bull. 28:1444–1449.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sohn EJ, Kang DG, Choi DH, Lee AS, Mun YJ,
Woo WH, Kim JS and Lee HS: Effect of methanol extract of Sorbus
cortex in a rat model of L-NAME-induced atherosclerosis. Biol Pharm
Bull. 28:1239–1243. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee SO, Lee HW, Lee IS and Im HG: The
pharmacological potential of Sorbus commixta cortex on blood
alcohol concentration and hepatic lipid peroxidation in acute
alcohol-treated rats. J Pharm Pharmacol. 58:685–693. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Na M, Kim BY, Osada H and Ahn JS:
Inhibition of protein tyrosine phosphatase 1B by lupeol and
lupenone isolated from Sorbus commixta. J Enzyme Inhib Med Chem.
24:1056–1059. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nikolaienko RM, Agyekum B and Bouyain S:
Receptor protein tyrosine phosphatases and cancer: new insights
from structural biology. Cell Adhes Migr. 6:356–364. 2012.
View Article : Google Scholar
|
|
20
|
Ostman A, Hellberg C and Böhmer FD:
Protein-tyrosine phosphatases and cancer. Nat Rev Cancer.
6:307–320. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu H, Kato Y, Erzinger SA, Kiriakova GM,
Qian Y, Palmieri D, Steeg PS and Price JE: The role of MMP-1 in
breast cancer growth and metastasis to the brain in a xenograft
model. BMC Cancer. 12:5832012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Choi HJ, Chung TW, Kim JE, Jeong HS, Joo
M, Cha J, Kim CH and Ha KT: Aesculin inhibits matrix
metalloproteinase-9 expression via p38 mitogen activated protein
kinase and activator protein 1 in lipopolysachride-induced RAW264.7
cells. Int Immunopharmacol. 14:267–274. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim JR and Kim CH: Association of a high
activity of matrix metalloproteinase-9 to low levels of tissue
inhibitors of metal-loproteinase-1 and -3 in human hepatitis
B-viral hepatoma cells. Int J Biochem Cell Biol. 36:2293–2306.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vandooren J, Van den Steen PE and
Opdenakker G: Biochemistry and molecular biology of gelatinase B or
matrix metalloproteinase-9 (MMP-9): the next decade. Crit Rev
Biochem Mol Biol. 48:222–272. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Deng L, Chen N, Li Y, Zheng H and Lei Q:
CXCR6/CXCL16 functions as a regulator in metastasis and progression
of cancer. Biochim Biophys Acta. 1806:42–49. 2010.PubMed/NCBI
|
|
27
|
Chatterjee S, Behnam Azad B and Nimmagadda
S: The intricate role of CXCR4 in cancer. Adv Cancer Res.
124:31–82. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mehlen P and Puisieux A: Metastasis: a
question of life or death. Nat Rev Cancer. 6:449–458. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen K, Zhang S, Ji Y, Li J, An P, Ren H,
Liang R, Yang J and Li Z: Baicalein inhibits the invasion and
metastatic capabilities of hepatocellular carcinoma cells via
down-regulation of the ERK pathway. PLoS One. 8:e729272013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lou L, Ye W, Chen Y, Wu S, Jin L, He J,
Tao X, Zhu J, Chen X, Deng A, et al: Ardipusilloside inhibits
survival, invasion and metastasis of human hepatocellular carcinoma
cells. Phytomedicine. 19:603–608. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wei PL, Tu CC, Chen CH, Ho YS, Wu CT, Su
HY, Chen WY, Liu JJ and Chang YJ: Shikonin suppresses the migratory
ability of hepatocellular carcinoma cells. J Agric Food Chem.
61:8191–8197. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chien ST, Lin SS, Wang CK, Lee YB, Chen
KS, Fong Y and Shih YW: Acacetin inhibits the invasion and
migration of human non-small cell lung cancer A549 cells by
suppressing the p38α MAPK signaling pathway. Mol Cell Biochem.
350:135–148. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chung TW, Moon SK, Chang YC, Ko JH, Lee
YC, Cho G, Kim SH, Kim JG and Kim CH: Novel and therapeutic effect
of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma
cells: complete regression of hepatoma growth and metastasis by
dual mechanism. FASEB J. 18:1670–1681. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chung TW, Lee YC and Kim CH: Hepatitis B
viral HBx induces matrix metalloproteinase-9 gene expression
through activation of ERK and PI-3K/AKT pathways: involvement of
invasive potential. FASEB J. 18:1123–1125. 2004.PubMed/NCBI
|
|
35
|
Bauvois B: New facets of matrix
metalloproteinases MMP-2 and MMP-9 as cell surface transducers:
outside-in signaling and relationship to tumor progression. Biochim
Biophys Acta. 1825:29–36. 2012.
|
|
36
|
Lee JY, Chung TW, Choi HJ, Lee CH, Eun JS,
Han YT, Choi JY, Kim SY, Han CW, Jeong HS, et al: A novel
cantharidin analog N-benzylcantharidinamide reduces the expression
of MMP-9 and invasive potentials of Hep3B via inhibiting cytosolic
trans-location of HuR. Biochem Biophys Res Commun. 447:371–377.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ieranò C, Santagata S, Napolitano M,
Guardia F, Grimaldi A, Antignani E, Botti G, Consales C, Riccio A,
Nanayakkara M, et al: CXCR4 and CXCR7 transduce through mTOR in
human renal cancer cells. Cell Death Dis. 5:e13102014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Xia Y, Yan J, Jin X, Entman ML and Wang Y:
The chemokine receptor CXCR6 contributes to recruitment of bone
marrow-derived fibroblast precursors in renal fibrosis. Kidney Int.
86:327–337. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Voermans C, Anthony EC, Mul E, van der
Schoot E and Hordijk P: SDF-1-induced actin polymerization and
migration in human hematopoietic progenitor cells. Exp Hematol.
29:1456–1464. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ganju RK, Brubaker SA, Meyer J, Dutt P,
Yang Y, Qin S, Newman W and Groopman JE: The alpha-chemokine,
stromal cell-derived factor-1alpha, binds to the transmembrane
G-protein-coupled CXCR-4 receptor and activates multiple signal
transduction pathways. J Biol Chem. 273:23169–23175. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sameermahmood Z, Balasubramanyam M,
Saravanan T and Rema M: Curcumin modulates SDF-1alpha/CXCR4-induced
migration of human retinal endothelial cells (HRECs). Invest
Ophthalmol Vis Sci. 49:3305–3311. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Qian Y, Corum L, Meng Q, Blenis J, Zheng
JZ, Shi X, Flynn DC and Jiang BH: PI3K induced actin filament
remodeling through Akt and p70S6K1: implication of essential role
in cell migration. Am J Physiol Cell Physiol. 286:C153–C163. 2004.
View Article : Google Scholar
|
|
43
|
Simon C, Simon M, Vucelic G, Hicks MJ,
Plinkert PK, Koitschev A and Zenner HP: The p38 SAPK pathway
regulates the expression of the MMP-9 collagenase via
AP-1-dependent promoter activation. Exp Cell Res. 271:344–355.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Popik W and Pitha PM: Early activation of
mitogen-activated protein kinase kinase, extracellular
signal-regulated kinase, p38 mitogen-activated protein kinase, and
c-Jun N-terminal kinase in response to binding of simian
immunodeficiency virus to Jurkat T cells expressing CCR5 receptor.
Virology. 252:210–217. 1998. View Article : Google Scholar
|
|
45
|
Hosokawa Y, Hosokawa I, Ozaki K, Nakae H
and Matsuo T: Human gingival fibroblasts express functional
chemokine receptor CXCR6. Clin Exp Immunol. 156:413–418. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liu YL, Huang CC, Chang CC, Chou CY, Lin
SY, Wang IK, Hsieh DJ, Jong GP, Huang CY and Wang CM:
Hyperphosphate-induced myocardial hypertrophy through the
GATA-4/NFAT-3 signaling pathway is attenuated by ERK inhibitor
treatment. Cardiorenal Med. 5:79–88. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Mirzapoiazova T, Kolosova IA, Romer L,
Garcia JG and Verin AD: The role of caldesmon in the regulation of
endothelial cytoskeleton and migration. J Cell Physiol.
203:520–528. 2005. View Article : Google Scholar
|
|
48
|
Eckhardt BL, Francis PA, Parker BS and
Anderson RL: Strategies for the discovery and development of
therapies for metastatic breast cancer. Nat Rev Drug Discov.
11:479–497. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Jiang YL and Liu ZP: Natural products as
anti-invasive and anti-metastatic agents. Curr Med Chem.
18:808–829. 2011. View Article : Google Scholar
|
|
50
|
Jones V and Katiyar SK: Emerging
phytochemicals for prevention of melanoma invasion. Cancer Lett.
335:251–258. 2013. View Article : Google Scholar : PubMed/NCBI
|
